MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 44 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2024. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $25,168 | -25.7% | 18,923 | 0.0% | 0.00% | – |
| Q1 2024 | $33,872 | -6.1% | 18,923 | -12.4% | 0.00% | – |
| Q4 2023 | $36,090 | -46.1% | 21,611 | 0.0% | 0.00% | – |
| Q3 2023 | $66,994 | +8.8% | 21,611 | 0.0% | 0.00% | – |
| Q2 2023 | $61,591 | -28.9% | 21,611 | -1.8% | 0.00% | – |
| Q1 2023 | $86,676 | -50.5% | 21,999 | -50.2% | 0.00% | – |
| Q4 2022 | $174,976 | -13.4% | 44,186 | +100.9% | 0.00% | – |
| Q3 2022 | $202,000 | +57.8% | 21,996 | +1.8% | 0.00% | – |
| Q2 2022 | $128,000 | -8.6% | 21,608 | -0.9% | 0.00% | – |
| Q1 2022 | $140,000 | +2.9% | 21,802 | +4.7% | 0.00% | – |
| Q4 2021 | $136,000 | +16.2% | 20,832 | +1.9% | 0.00% | – |
| Q3 2021 | $117,000 | +28.6% | 20,448 | +23.0% | 0.00% | – |
| Q2 2021 | $91,000 | -8.1% | 16,626 | -2.3% | 0.00% | – |
| Q1 2021 | $99,000 | -13.2% | 17,016 | 0.0% | 0.00% | – |
| Q4 2020 | $114,000 | -11.6% | 17,016 | -3.1% | 0.00% | – |
| Q3 2020 | $129,000 | – | 17,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,980,400 | $10,893,000 | 0.88% |
| Novo Holdings A/S | 2,530,585 | $13,918,000 | 0.62% |
| Boxer Capital, LLC | 2,572,194 | $14,147,000 | 0.50% |
| RTW INVESTMENTS, LP | 4,315,102 | $23,733,000 | 0.36% |
| RA Capital Management | 2,246,503 | $12,356,000 | 0.20% |
| Orbimed Advisors | 2,583,821 | $14,211,000 | 0.14% |
| PURA VIDA INVESTMENTS, LLC | 702,545 | $3,864,000 | 0.12% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $4,682,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 224,758 | $1,236,000 | 0.04% |
| SG3 Management, LLC | 40,000 | $220,000 | 0.01% |